Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-VEGFR2/CD309 a été validé pour WB. Il convient pour détecter VEGFR2/CD309 dans des échantillons de Humain.
N° du produit ABIN7466284

Aperçu rapide pour VEGFR2/CD309 anticorps (C-Term) (ABIN7466284)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 317
  • 205
  • 139
  • 17
  • 10
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 286
  • 65
  • 37
  • 3
  • 1
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 276
  • 119
Polyclonal

Conjugué

  • 173
  • 34
  • 19
  • 13
  • 11
  • 9
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est non-conjugé

Application

  • 213
  • 117
  • 115
  • 114
  • 63
  • 28
  • 26
  • 26
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 38
    • 33
    • 26
    • 23
    • 20
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 8
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

     Réactivité croisée

    Humain

    Purification

    Purified by antigen-affinity chromatography.

    Immunogène

    Recombinant protein encompassing a sequence within the C-terminus region of human VEGF Receptor 2. The exact sequence is proprietary.

    Isotype

    IgG
  • Indications d'application

    WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

    Commentaires

    Positive Control: HUVEC

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    kinase insert domain receptor

    Sujet

    Kinase insert domain receptor , CD309 , FLK1 , VEGFR , VEGFR2,Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq]

    Poids moléculaire

    152 kDa

    ID gène

    3791

    UniProt

    P35968

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!